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Background: There is ongoing controversy regarding the validity of controlled diagnostic blocks due to variability in sensitivity, specificity, and accuracy. Consequently, identification of false-positive rates, false-negative rates, and placebo responses is crucial. The reasons
described for false-positive responses to diagnostic anesthetic blocks are many; however, sedation and psychological factors have been implied as causes. Further, there is no consensus
with regards to sedation prior to controlled diagnostic blocks and their influence on the accuracy and validity of a diagnosis.
Study Design: A systematic review of the literature evaluating the influence of sedation on
diagnostic spinal interventional techniques.
Objectives: To systematically assess the quality of clinical studies evaluating the diagnostic
accuracy of controlled diagnostic blocks in the diagnosis of chronic spinal pain.
Methods: A comprehensive evaluation of the literature relating to sedation in diagnostic interventional techniques was performed. The methodologic quality assessment of the studies
was carried out by utilizing Agency for Healthcare Research and Quality (AHRQ) methodologic quality criteria with scores of 50 or higher included in the assessment of the level of evidence. Level of evidence was based on the U.S. Preventive Services Task Force (USPSTF) criteria for the assessment of accuracy of diagnostic studies.
Limitations: All 3 of the studies were produced by one group of authors. Thus paucity of
the literature on the subject of facet joint pain and the lack of literature on the subjects of discogenic pain and sacroiliac joint pain are major limitations.
Results: Three studies were identified which met inclusion and methodologic assessment
quality criteria. Sedation can be a confounding factor in a small population of patients specifically if fentanyl is employed and non-stringent criteria are followed. Based on the 3 randomized double-blind trials with stringent criteria utilizing 80% pain relief and the ability to perform prior painful movements without any significant pain following the diagnostic injection
in evaluation of facet joint pain, the indicated evidence is Level II-1.
Conclusion: This systematic review provides no significant evidence of the influence of sedation either with midazolam or fentanyl in the evaluation of cervical and lumbar facet joint
pain with controlled cervical and lumbar facet joint nerve blocks with an indicated evidence
of Level II-1, with application of stringent criteria of at least 80% pain relief and the ability to
perform previously painful movements after the diagnostic blocks.
Key words: Sedation, chronic spinal pain, anxiolytics, analgesics, controlled diagnostic
nerve blocks, opioids, benzodiazepines, zygapophysial or facet joint blocks, provocation discography, sacroiliac joint injections
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volution and phenomenal growth of
interventional pain management (IPM) (15) has led almost all interventional pain
physicians to encounter patients with chronic,
persistent spinal pain with psychological problems
who also have been exposed to opioids (6-11).
Among chronic pain disorders, pain arising from
various structures of the spine constitutes the
majority of the problems (6). However, due to
the inability of physical examination, clinical
symptoms, radiologic evaluation, and nerve
conduction studies to provide a reliable diagnosis
of the structural origin of pain in a patient with
chronic pain without disc herniation and radiculitis,
controlled diagnostic blocks are considered the
only means of reliable diagnosis of spinal pain (68,12-16). The most commonly performed diagnostic
interventional techniques include diagnostic facet
joint nerve blocks, discography, and sacroiliac joint
injections (6). Based on the controlled evaluations,
lumbar facet joint pain has been demonstrated in
15% to 45% of the patients, with a false-positive
rate of 17% to 50% (17-29), discogenic pain has
been demonstrated in 26% to 39% (17,30), with a
significant alleged false-positive rate (31), with a
prevalence of sacroiliac joint pain in 10% to 26%
with a false-positive rate of 20% to 22% (17,32,33).
Similarly in the cervical spine, facet joint pain was
determined in 36% to 67% of the patients with
chronic neck pain with a false-positive rate of 27%
to 63% (18,20,28,34-39) with a reported prevalence
of cervical discogenic pain in 16% to 20% of the
patients (39,40). However, while there is no data
available on the thoracic spine for prevalence of
discogenic pain (41), facet joints were shown to be
involved in 34% to 48% of patients with chronic
thoracic pain with a false-positive rate of 42% to
58% (18,20,42,43).
There is ongoing controversy regarding the validity of controlled diagnostic blocks of facet joints. In
general, precision diagnostic techniques are variable
in sensitivity, specificity, and accuracy. Thus, identification of false-positive rates, false-negative rates, and
placebo responses is crucial. Numerous reasons have
been described for false-positive responses to diagnostic anesthetic blocks, including placebo response
to diagnostic injections, use of sedation, liberal use
of superficial local anesthetic, and the spread of injectate to pain generating structures other than those
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targeted (44-46). False-positive responses may also be
due to the psychological status of the patient and the
effects of various drugs have been suggested to affect
false-positive rates by interfering with the interpretation of the analgesic response to controlled diagnostic blocks. Further, psychological variables such as
depression, anxiety, and excessive somatic symptoms
are recognized as actively contributing to a patient’s
perception of pain (47-52). In addition, a diagnosis of
depression correlates with increased pain (53-55) and
anxiety decreases a patient’s pain threshold and tolerance (56). In samples evaluating chronic pain patients,
rates of current major depression and anxiety ranged
from 15% to 59%, significantly higher than the rate
of 5% to 10% in persons without pain found in the
general population (57-63).
Consequently, there is ongoing controversy regarding the validity of controlled diagnostic blocks.
Carragee et al (64-67), and others (44-46,68) have
raised numerous questions about the value of controlled diagnostic blocks. Cohen and Raja (44) described that both opioids and sedatives, such as
midazolam, can lead to false-positive responses by
producing general analgesia and/or muscle relaxingproperties that interfere with analgesic responses of
controlled diagnostic blocks. However, Manchikanti
et al (11,69,70) showed that psychological factors may
not have significant influence on the diagnostic validity of interventional techniques in discogenic and
facet joint pain. Manchikanti et al (71-74) have also
shown that midazolam sedation exerts only a minimal
effect on the diagnostic accuracy of controlled blocks
of the cervical and lumbar facet joints in the diagnosis
of facet joint pain. In addition, Manchikanti et al (75)
have also demonstrated that prior exposure to opioids
has no significant effect on the diagnostic validity of
controlled comparative local anesthetic blocks in the
diagnosis of chronic pain of spinal origin.
Consequently, the issue of providing procedural
sedation in interventional pain management specifically for diagnostic techniques remains controversial.
Further, there is no consensus with regards to sedation prior to controlled diagnostic blocks and the influence of sedation on the accuracy and validity of the
diagnosis.
This systematic review was undertaken to review
the literature to arrive at appropriate recommendations for utilization of sedation for controlled diagnostic blocks in evaluation of chronic spinal pain.
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Methods
Literature Search
A literature search included multiple databases including PubMed, EMBASE, and databases of multiple
journals, Cochrane Reviews, systematic and narrative
reviews, Clinical Trials Registry, cross references, and
letters to the experts. A search was conducted from
1966 through November 2008.
The search terminology included interventional
techniques, controlled diagnostic blocks, controlled
comparative local anesthetic blocks, role of sedation
for diagnostic blocks, role of opioids, role of anxiolytics, provocation discography, facet or zygapophysial
joint nerve blocks.

Inclusion Criteria
Inclusion criteria concentrated on clinical relevance with types of studies concentrating on the role
of sedation, anxiety on the diagnosis of spinal facet,
discogenic, or sacroiliac joint pain.

Exclusion criteria included abstracts, publications
in non-peer reviewed journals, technical reports, expert opinions, general review articles, and single case
reports.

Review Methods
Study Selection
Studies were selected if they met inclusion
criteria.

Data Extraction
Relevant data on methodology and outcomes
were collected.

Methodologic Quality Assessment
The Agency for Healthcare Research and Quality
(AHRQ) criteria for diagnostic testing (76) as reported in
Table 1 were used for methodologic quality assessment.
Based on the weighted scoring system developed and
revised by consensus of the Guidelines Committee of
the American Society of Interventional Pain Physicians

Table 1. Modified AHRQ methodologic assessment criteria for diagnostic interventions.
CRITERION
1. Study Population

Weighted Score
(points)
15

• Subjects similar to populations in which the test would be used and with a similar spectrum of disease
2. Adequate Description of Test

10

• Details of test and its administration sufficient to allow for replication of study
3. Appropriate Reference Standard

30

• Appropriate reference standard (gold standard) used for comparison

15

• Reference standard reproducible

15

4. Blinded Comparison of Test

30

• Evaluation of test without knowledge of disease status, if possible

15

• Independent, blind interpretation of test and reference

15

5. Avoidance of Verification Bias

15

• Decision to perform reference standard not dependent on results of test under study
TOTAL SCORE

100

Adapted and modified from West et al. Systems to Rate the Strength of Scientific Evidence, Evidence Report, Technology Assessment No. 47.
AHRQ Publication No. 02-E016 (76).
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(ASIPP) (12), a total of 100 total points may be awarded for each study. This system has been employed in
other systematic reviews (41,42). Only studies scoring
50 or above were used in the analysis. Each study was
scored independently by 2 reviewers. Any discrepancies
or conflicts were arbitrated by a third author to reach
a consensus agreement. Any disagreement among the
reviewers was resolved by discussion and consensus. If
there was a conflict of interest with the reviewed manuscript with authorship or any other type of conflict,
the involved authors did not review the manuscript for
quality assessment or evidence synthesis.

Qualitative Analysis of Evidence
Qualitative analysis was conducted using 5 levels
of evidence, ranging from Level I to III with 3 subcategories in Level II, as illustrated in Table 2 (77).

Results
Literature Search
Methodologic Quality Assessment
Figure 1 illustrates the search results. The search
yielded 107 articles for review, of these, only 6 were
relevant to the study question, with 2 studies evaluating role of sedation for non-specific intervention techniques (78,79), and 4 studies evaluating the role of
sedation for diagnostic interventional techniques (7174). Methodologic quality assessment of the 6 relevant
studies (71-73) met the inclusion criteria for methodologic quality assessment. Two studies (78,79) were not
included as they were not related specifically to diagnostic interventions and also the role of sedation and
its influence on diagnostic value and validity was not
evaluated. Further, one study (74) was the evaluation
of the role of placebo and nocebo effects of perioperative administration of sedatives and opioids in in-

terventional pain management on the data obtained
from the previous controlled studies (71-73).
Table 3 illustrates the methodologic quality assessment of studies evaluating the effect of sedation.
There were no studies available evaluating the influence of sedation on diagnostic value or validity of either discogenic pain or sacroiliac joint pain.

Study Methods
In 2 studies (71,72), there were 60 patients in each
group. In the third study (73) there were 20 patients
in each group. Each patient, based on the randomization, received 1 of the 3 solutions in incremental doses
of 1 mL with a maximum of 5 mL in all groups; 5 mL of
NaCl in Group I, 1 mg of midazolam per mL (5 mg per
5 mL) in Group II, or 50 mcg of fentanyl per mL (250
mcg per 5 mL) in Group III. Patient and investigator
were blinded to the allocation sequence, as well as the
solution administered, in all cases. The solutions were
administered slowly based on the patient’s response
with relaxation and/or a feeling of drowsiness or until
the entire syringe of 5 mL was administered. Once the
patients expressed either drowsiness or relaxation or
the maximum dose was administered, assessment of
pain on a numeric pain scale and the ability to perform
pre-sedation painful movements were reassessed. After completion of the evaluation, unblinding was carried out and the amount of sedation administered in
Groups II and III were noted on the record.

Outcomes Assessment
In all studies, the outcomes were assessed at
baseline prior to the administration of the solution
and after the administration of the solution. Multiple parameters included numeric pain scale, percent
of pain relief, and ability to perform prior painful
movements.

Table 2. Modified quality of evidence developed by AHRQ.
I:

Evidence obtained from at least one properly randomized controlled trial or multiple well-conducted diagnostic studies

II-1:

Evidence obtained from well-designed controlled trials without randomization or at least one well-controlled diagnostic study of
adequate size

II-2:

Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research
group or evidence obtained from at least one properly designed small diagnostic accuracy study

II-3:

Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments
(such as the results of the introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence

III:

Opinions of respected authorities, based on clinical experience descriptive studies and case reports or reports of expert committees

Adapted from the U.S. Preventive Services Task Force (USPSTF) (77).
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Computerized and manual search of
literature
n = 107

Non-duplicate titles
n = 91

Articles with Abstracts
n = 87

Abstracts excluded
n = 47

Full manuscripts not available
n=0

Full manuscripts reviewed
n = 30

Manuscripts considered for inclusion:
Original studies
n=6

Fig. 1. The flow diagram of the selection process of the literature.
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Table 3. Methodologic quality assessment and scoring
3.
Appropriate Reference
Standard
(30)

2.
Adequate Appropriate
reference
Description
standard
Reference
of Test
(gold
standard
(10)
standard) reproducible
used for
(15)
comparison
(15)

4.
Blinded Comparison of
Test
(30)

5.
Avoidance
of
TOTAL
Verification (100)
Bias
(15)

Study

1.
Study
Population
(15)

Manchikanti et al
2004 (72)

15

0

__

15

__

15

15

70

Manchikanti et al
2004 (71)

15

0

__

15

__

15

15

70

Manchikanti et al
2006 (73)

15

0

__

15

__

15

15

70

Evaluation
of test
without
knowledge
of disease
status, if
possible
(15)

Independent,
blind
interpretation
of test and
reference
(15)

( ) weighted item score
Methodological criteria and scoring adapted from West et al. Systems to Rate the Strength of Scientific Evidence, Evidence Report, Technology
Assessment No. 47. AHRQ Publication No. 02-E016 (76).

Descriptive Characteristics
Descriptive characteristics of these 3 studies are included in Table 4. All 3 studies (71-73) were performed
by the same group utilizing the same methodology.
Manchikanti et al (71) performed a randomized, placebo-controlled, double-blind study and demonstrated that 2% of the patients in Group I (placebo group
– NaCl solution), 5% in Group II (midazolam group),
and 7% in Group III (fentanyl group) had experienced
≥ 80% pain relief and were able to perform baseline
painful movements in the post follow-up period in
patients with chronic low back pain of lumbar facet
joint origin. Further, evaluation of significant relief of
≥ 50% relief with ability to perform baseline painful
movements in the post follow-up period was seen in
7%, 5%, and 13% of the patients in Groups I, II, and III.
Significant differences were only noted with regards
to the relaxation status with 40% in Group I, 93% in
Group II, and 87% in Group III. This study showed no
significant differences between the pain relief and
ability to perform painful movements in any of the
groups.
Manchikanti et al (72) performed a randomized,
prospective, double-blind, placebo-controlled evaluation on the effect of sedation in the diagnostic validity
of cervical facet joint pain. Pain relief of ≥ 80% was
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noted in 5% of the patients in Group I, 8% in Group II,
and 8% in Group III. However, pain relief of ≥ 50% was
noted in 8% of the patients in Group I, 13% in Group
II, and 27% in Group II. (72).
In the study by Manchikanti et al (73), 50% to
100% of the patients reported relaxation, and as
many as 10% of the patients experienced significant
pain relief (80% or greater) and were able to perform
movements that were painful prior to the administration of intravenous sodium chloride, midazolam, or
fentanyl. There were no significant differences noted
either among the groups or between regions (cervical
vs. lumbar). Significant differences were noted only
with regards to relaxation status, with 50% reported
in Group I and 100% in Groups II and III. Thus, overall
this study showed no significant differences in any of
the groups between pain relief or the ability to perform painful movements and the type of sedation.
Based on the results of a randomized, placebocontrolled evaluation, 13% to 30% of all the patients
receiving either sodium chloride solution, midazolam,
or fentanyl reported a placebo response (74). A small
proportion (3% to 8%) of patients also reported a
nocebo response, where they felt worse. The majority of the patients (67% to 79%) described no significant change from their previous experience. It is con-
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Table 4. Descriptive characteristics of sedation for interventional techniques.
Study/Methods

Participants

Intervention(s)

Outcome(s)

Result(s)

Conclusion(s)

Manchikanti et al
(72) 2004

180 patients
with cervical
facet joint
pain

Randomization
into 3 equal groups
(60/group); titration
of agent 1 mL at
a time; relaxed or
5 mL max given.
Group I – NaCl
Group II
– midazolam
Group III - fentanyl

80% pain
relief and
ability to
perform
previously
painful
movements

Pain relief of > 80%
was noted in 5% of the
patients in Group I, 8%
in Group II, and 8% in
Group III. However, >
50% relief was noted
in 8% of the patients
in Group I, 13% of the
patients in Group II,
and 27% of the patients
in Group III. Overall,
8% of the patients in
Group I, 13% in Group
II, and 27% in Group
III were able to perform
movements which were
painful prior to injection.

The administration of sedation
with midazolam or fentanyl is a
confounding factor in the diagnosis
of cervical facet joint pain in
patients with chronic neck pain.
However, if > 80% pain relief
with the ability to perform prior
painful movements is used as the
standard for evaluating the effect of
controlled local anesthetic blocks,
the diagnostic validity of cervical
facet joint nerve blocks may be
preserved.

180 patients
with lumbar
facet joint
pain

Randomization
into 3 equal groups
(60/group); titration
of agent 1 mL at a
time; relaxed or 5
mL max given
Group I – NaCl
Group II
– midazolam
Group III – fentanyl

80% pain
relief and
ability to
perform
previously
painful
movements

Pain relief of > 80%
was noted in 2% of the
patients in Group I, 5%
of the patients in Group
II, and 7% in Group
III. Pain relief of > 50%
was noted in 7% of the
patients in Group I, 5% of
the patients in Group II,
and 13% of the patients
in Group III. There were
no significant differences
among the groups.

The administration of sedation
with midazolam or fentanyl is a
confounding factor in the diagnosis
of lumbar facet joint pain in
patients with chronic low back
pain. However, this study suggests
that if strict criteria including pain
relief and the ability to perform
prior painful movements is used
as the standard for evaluating the
effect of controlled local anesthetic
blocks, the diagnostic validity of
lumbar facet joint nerve blocks may
be preserved.

60 patients
with
combined
cervical facet
joint pain and
lumbar facet
joint pain

Randomization
into 3 equal groups
(20/group); titration
of agent 1 mL at a
time; relaxed or 5
mL max given
Group I – NaCl
Group II
– midazolam
Group III - fentanyl

80% pain
relief and
ability to
perform
previously
painful
movements

Overall, 50% of the
patients were relaxed or
sedated in the placebo
group, while 100%
of the patients in the
midazolam and fentanyl
groups were relaxed or
sedated. As many as 10%
of the patients reported
significant relief
(≥ 80%) with the ability
to perform prior painful
movements.

Perioperative administration of
sodium chloride, midazolam, or
fentanyl can confound results in
the diagnosis of combined cervical
and lumbar facet joint pain. Falsepositive results with placebo or
sedation may be seen in a small
proportion of patients.

Randomized,
double-blind

Manchikanti et al
(71) 2004
Randomized,
double-blind

Manchikanti et al
(73) 2006
Randomized,
double-blind

cluded that sodium chloride, midazolam, and fentanyl
are capable of producing placebo, as well as nocebo,
responses in patients undergoing interventional procedures. In designing research and interpreting outcomes, placebo and nocebo effects must be taken into
consideration.
In all the studies (71-73), Manchikanti et al concluded that prudent administration of intravenous
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preoperative sedative dose of a narcotic such as fentanyl or an anxiolytic such as midazolam is no more
likely to cause a small proportion of patients to report
false-positive pain relief with active motion testing
than sodium chloride placebo. These studies suggested that the prudent administration of midazolam and
fentanyl to patients who are not relaxed may not have
any significant adverse effect on the diagnostic valid-
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ity of controlled comparative local anesthetic blocks in
the cervical or lumbar spine.
Finally, the previous exposure to the study drugs
has been shown not to have any significant effect on
the response during diagnostic blockade (75).

Level of Evidence
Based on the 3 studies (71-73) evaluating the influence of sedation on the diagnostic accuracy in the
diagnosis of facet joint pain, based on United States
Preventive Services Task Force (USPSTF) criteria (77),
as shown in Table 2 criteria, the indicated evidence
is Level II-1, in the evaluation of cervical and lumbar
facet joint pain.

Discussion
Based on the comprehensive evaluation of all
the available literature, the lack of influence of sedation on controlled facet joint nerve blocks on the
diagnosis of cervical and lumbar facet joint pain,
the indicated evidence is Level II-1. All of the studies showed a lack of influence of sedation either
with midazolam or even with fentanyl with criterion
standard of 80% pain relief and the ability to perform previously painful movements. The false-positive results were obtained in 7% of the patients with
lumbar facet joint nerve blocks in Group III receiving
fentanyl, whereas it was 8% in patients with cervical facet joint pain. However, the authors have cautioned that with an application of 50% pain relief as
the criterion standard, this proportion will increase
to 13% with lumbar facet joint nerve blocks, whereas
it would increase to 27% in the cervical group. Based
on the results of this systematic review it is postulated that appropriate administration of sedation
either with midazolam or with fentanyl will not adversely affect the diagnostic validity of diagnostic
facet joint nerve blocks either in the cervical spine or
lumbar spine. However, 80% pain relief with the ability to perform previously painful movements should
be used as a criterion standard. Any other standard
is not applicable.
This systematic review showed a significant paucity of literature and multiple methodological challenges in assessing the influence of sedation on diagnostic
interventional techniques. We were able to find only
3 manuscripts (71-73) by the same authors evaluating
either cervical and/or lumbar facet joint pain. There
were no studies evaluating provocation discography
or sacroiliac joint blocks. Further, this evaluation has
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not included patients with combined midazolam and
fentanyl. Based on the present systematic review, it
appears that a significant proportion of patients may
require sedation during the perioperative period of
diagnostic interventional techniques (78-80).
In fact, Cucuzzella et al (78) performed a survey
of 500 consecutive patients receiving lumbar, thoracic,
and/or cervical spinal injections. A 12-item questionnaire assessing patients’ perceived anxiety was administered before a spinal injection. Subjects were also
given the questionnaire after their primal injection.
Percentages requesting sedation for a first and potential second procedure were assessed. Additionally,
anxiety level and pain rating, location of injection,
age, sex, and other medication use were analyzed
to determine the effect on the request for sedation.
Seventeen percent of patients questioned requested
sedation before an injection and 28% would request
sedation if they were to have a second injection. Cucuzzella and colleagues (78) concluded that routine
sedation before diagnostic and therapeutic injections
is not necessary as the majority of patients would not
request sedation before the procedure when given
the option. However, in some patients sedation is indicated, and many patients may benefit from educational material on sedation before the injection.
In another study from the same institution, Kim
et al (79) conducted a study with 301 consecutive spinal injection patients given a choice to take oral or
IV diazepam, or no sedation before a spinal injection.
All participating patients filled in a validated anxiety questionnaire before the injection. Patients were
asked after the injection whether they were satisfied
with their decision regarding sedation and whether
their anxiety was controlled effectively. One hundred
fifty-seven patients (58%) chose to have IV sedation. Of those, 141 (90%) indicated that their anxiety
was controlled. Eleven (7%) did not think that their
anxiety was controlled and 5 (3%) did not provide a
response.
As eluded by Manchikanti and Giordano (80), Kim
et al (79) showed that 58% of the patients initially
chose to be sedated and this number increased after
the first intervention. However, in their previous study
by Cucuzzella et al (78) only 17% of the patients requested sedation initially reflecting a wide variance.
Consequently, it is important to consider the differences in the physical and psychological characteristics
of patients as seen by interventional physiatrists and
interventional pain physicians.
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Multiple drugs utilized for anxiolysis and analgesia during interventional procedures include benzodiazepines, opioids, and other agents (81). Midazolam
and fentanyl are more frequently used intervenous
drugs for intraoperative sedation and analgesia due
to the expected short duration of action combined
with rapid onset of action. Midazolam is a short-acting benzodiazepine affecting the central nervous system depressant activities. The effects of midazolam
on the central nervous system are dependent on the
dose administered, the route of administration, and
the presence or absence of other medications. Clinical
experience has shown midazolam to be 3 to 4 times as
potent per mg as diazepam.
Fentanyl is a narcotic analgesic. A dose of 100
mcg or 0.1 mg or 2 mL is approximately equivalent in
analgesic activity to 10 mg of morphine or 75 mg of
meperidine. The principle actions of therapeutic value are analgesia and sedation. The onset of action of
fentanyl is almost immediate when the drug is given
intravenously.
The present evaluation may be criticized for
several potential drawbacks of the included studies
(71-73). However, all the studies were placebo-controlled, randomized, double-blind, with 60 patients
in the smallest group in 3 groups in 2 studies (71,72),
with appropriate evaluation of outcome parameters
of pain relief and the ability to perform prior painful movements. The question about an additional
group with midazolam and fentanyl may be legitimate. However, administration of the 2 drugs in a
safe manner would have been extremely difficult,
specifically limiting the total dosage to 5 mL with
50% midazolam and 50% fentanyl. The drugs cannot
be mixed reliably and uniformly. Further, they may
have to be provided in 2 separate syringes. In such
a scenario, the study would not be blind. Thus, the
authors explained that the combined effect of midazolam with fentanyl was not evaluated.
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This systematic review utilized stringent criteria for
inclusion. In the evidence synthesis, we attempted to
evaluate all types of diagnostic studies, however only
limited data was available. Further, since the publication of this literature, Manchikanti et al (75) have illustrated a significant lack of influence of prior exposure on the diagnostic validity of controlled facet joint
injections. Even then, it is prudent to conduct multiple
studies not only evaluating the role of sedation in diagnosing facet joint pain, but also in the diagnosis of
discogenic and sacroiliac joint pain and all other types
of diagnostic interventions. Consequently, the limitations of this manuscript include the paucity of the data
in general and the lack of availability of data in evaluation of the influence of sedation, with or without opioids, in the diagnosis of discogenic pain and sacroiliac
joint pain.

Conclusion
This systematic review provides no significant evidence of the influence of sedation either with midazolam or fentanyl in the evaluation of cervical and
lumbar facet joint pain with controlled cervical and
lumbar facet joint nerve blocks with indicated evidence of Level II-1. However, the results of this systematic review only apply for cervical and lumbar facet
joint blocks under sedation utilizing the criterion standard of 80% pain relief with controlled comparative
local anesthetic blocks with the ability to perform prior painful movements by the patient immediately.
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